APA 6th Edition

Perčin, I. (2014). The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab. Reumatizam, 61 (2), 167-167. Preuzeto s https://hrcak.srce.hr/137960

---

MLA 8th Edition

Perčin, Iva. "The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab." Reumatizam, vol. 61, br. 2, 2014, str. 167-167. https://hrcak.srce.hr/137960. Citirano 06.01.2025.

---

Chicago 17th Edition

Perčin, Iva. "The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab." Reumatizam 61, br. 2 (2014): 167-167. https://hrcak.srce.hr/137960

---

Harvard

Perčin, I. (2014). 'The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab', Reumatizam, 61(2), str. 167-167. Preuzeto s: https://hrcak.srce.hr/137960 (Datum pristupa: 06.01.2025.)

---

Vancouver

Perčin I. The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab. Reumatizam [Internet]. 2014 [pristupljeno 06.01.2025.];61(2):167-167. Dostupno na: https://hrcak.srce.hr/137960

---

IEEE

I. Perčin, "The pathophysiology of rheumatoid arthritis and mechanism of action of subcutaneous tocilizumab", Reumatizam, vol.61, br. 2, str. 167-167, 2014. [Online]. Dostupno na: https://hrcak.srce.hr/137960. [Citirano: 06.01.2025.]